Clinical Trial Detail

NCT ID NCT01721603
Title A Phase 2 Prospective Trial of Dabrafenib With Stereotactic Radiosurgery in BRAFV600E Melanoma Brain Metastases
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors University of California, San Francisco
Indications

melanoma

Therapies

Dabrafenib

Age Groups: adult

Additional content available in CKB BOOST